United Therapeutics Corporation (UTHR) earnings · P/E 19, rev $3.18B
These earnings events as JSON? API free 100/dayUnited Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
This UTHR earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported UTHR revenue for 2025-12-31 was $3.18B. Net income was $1.33B. Revenue was up 10.6% from 2024-12-31 to 2025-12-31. UTHR currently screens at market cap $23.41B and trailing P/E 19.4.
When the next UTHR 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 10.6% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full UTHR research stays on the stock page; the tape stays on the quote page.
UTHR earnings FAQ
What are UTHR's latest revenue and net income?
Latest cached United Therapeutics Corporation (UTHR) revenue for Dec 31, 2025 was $3.18B. Net income was $1.33B. Statements: https://lician.com/financials/uthr
What is UTHR's latest diluted EPS?
Latest cached United Therapeutics Corporation (UTHR) diluted EPS for Dec 31, 2025 was $27.86.
What period does the latest UTHR earnings print cover?
The latest cached United Therapeutics Corporation (UTHR) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did UTHR revenue change from the prior cached period?
Cached United Therapeutics Corporation (UTHR) revenue was up 10.6% from $2.88B (Dec 31, 2024) to $3.18B (Dec 31, 2025). Statements: https://lician.com/financials/uthr
What is UTHR's P/E ratio?
United Therapeutics Corporation (UTHR) trailing P/E is 19.4 on the latest cached fundamentals snapshot.
Where are UTHR earnings listed?
Cached earnings facts for United Therapeutics Corporation (UTHR) are listed at https://lician.com/earnings/uthr. Statements: https://lician.com/financials/uthr
Not investment advice.